Chong Kun Dang sees slow Penzal drink sales

Published: 2009-07-21 06:57:00

Updated: 2009-07-21 06:57:00

Penzal tablet is a very popular pain reliever in the domestic market, but the sales of its drink form is far below the firm's expectation since its launching at the end of last year.

Such a performance is disappointing for Chong Kun Dang, considering its intensive marketing assaults toward pha...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK